LUMOS PHARMA INC - Common Stock (LUMO)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock
Shares outstanding
8,122,625
Total 13F shares
3,314,846
Share change
-448,650
Total reported value
$38,788,642
Price per share
$11.70
Number of holders
33
Value change
-$8,023,294
Number of buys
17
Number of sells
17

Institutional Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q1 2021

As of 31 Mar 2021, LUMOS PHARMA INC - Common Stock (LUMO) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,314,846 shares. The largest 10 holders included NEA Management Company, LLC, Blackstone Group Inc., Lion Point Capital, LP, Opaleye Management Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, WELLS FARGO & COMPANY/MN, Jefferies Group LLC, and BlackRock Inc.. This page lists 33 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.